Smart drug that strips cancer cells of ‘invisibility cloak’ can shrink tumours by 30%, trial shows
types included in the trial. The drug halted progression of the disease for at least six months in 18% of cervical cancer patients, 32% of liver cancer patients, 36% of bladder cancer patients